AU560450B2 - Compositions of arginine and lysine - Google Patents

Compositions of arginine and lysine

Info

Publication number
AU560450B2
AU560450B2 AU72336/81A AU7233681A AU560450B2 AU 560450 B2 AU560450 B2 AU 560450B2 AU 72336/81 A AU72336/81 A AU 72336/81A AU 7233681 A AU7233681 A AU 7233681A AU 560450 B2 AU560450 B2 AU 560450B2
Authority
AU
Australia
Prior art keywords
arginine
lysine
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU72336/81A
Other languages
English (en)
Other versions
AU7233681A (en
Inventor
Massimo Baldacci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratori Baldacci SpA
Original Assignee
Laboratori Baldacci SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratori Baldacci SpA filed Critical Laboratori Baldacci SpA
Publication of AU7233681A publication Critical patent/AU7233681A/en
Application granted granted Critical
Publication of AU560450B2 publication Critical patent/AU560450B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU72336/81A 1980-06-30 1981-06-29 Compositions of arginine and lysine Ceased AU560450B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT23101/80A IT1131854B (it) 1980-06-30 1980-06-30 Composizione farmaceutica per uso terapeutico,per uso diagnostico e quale integratore alimentare
IT23101/80 1980-06-30

Publications (2)

Publication Number Publication Date
AU7233681A AU7233681A (en) 1982-01-14
AU560450B2 true AU560450B2 (en) 1987-04-09

Family

ID=11203787

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72336/81A Ceased AU560450B2 (en) 1980-06-30 1981-06-29 Compositions of arginine and lysine

Country Status (9)

Country Link
JP (1) JPS5714530A (xx)
AU (1) AU560450B2 (xx)
CH (1) CH649222A5 (xx)
DE (1) DE3115322A1 (xx)
FR (1) FR2485371A1 (xx)
GB (1) GB2078516B (xx)
IT (1) IT1131854B (xx)
PT (1) PT73286B (xx)
ZA (1) ZA814430B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3314079A1 (de) * 1982-04-19 1983-12-22 Papst Motoren Gmbh & Co Kg Mehrwellenlaufwerk fuer kassetierte signaltraeger
DE3242501C1 (de) * 1982-11-18 1984-03-29 Degussa Ag, 6000 Frankfurt Verwendung von waessrigen L-Lysin-Loesungen zur Supplementierung von Futtermitteln mit L-Lysin
FR2568124B1 (fr) * 1984-07-24 1988-12-09 Cortial Medicament pour traiter les etats hypotrophiques par administrations d'aspartate d'arginine
US5077313A (en) * 1988-11-25 1991-12-31 Gert Lubec Process for inhibiting pathological collagen cross-linking in diabetes patients
AT393080B (de) * 1988-11-25 1991-08-12 Lubec Gert Pharmazeutische verwendung von arginin (salzen)
AT393079B (de) * 1989-03-06 1991-08-12 Lubec Gert Pharmazeutische verwendung von agmatin
US6143786A (en) * 1999-02-02 2000-11-07 Novartis Nutrition Ag Oral arginine and insulin secretion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6588M (xx) * 1967-10-11 1968-12-30

Also Published As

Publication number Publication date
GB2078516A (en) 1982-01-13
FR2485371B1 (xx) 1985-04-12
ZA814430B (en) 1982-09-29
GB2078516B (en) 1985-02-27
JPS5714530A (en) 1982-01-25
AU7233681A (en) 1982-01-14
PT73286B (en) 1982-07-22
FR2485371A1 (fr) 1981-12-31
PT73286A (en) 1981-07-01
DE3115322A1 (de) 1982-04-08
IT8023101A0 (it) 1980-06-30
CH649222A5 (it) 1985-05-15
IT1131854B (it) 1986-06-25

Similar Documents

Publication Publication Date Title
GB2071670B (en) Nutrient compositions and methods of administering the same
AU538739B2 (en) Esters of acyl-carnitines
AU532124B2 (en) Preparation of bis-phenoxides and bisimides
AU544945B2 (en) Antigingirites composition of tranexamic acid and folic acid
AU544255B2 (en) Solid formulations of pheromiones
AU5289686A (en) Compositions and methods for retarding the effects of aging of the skin
AU540859B2 (en) L-carnitine and l-acylcarniture compositions
AU539279B2 (en) Preparation of dialkyldithiophosphinates
AU539547B2 (en) Blend of polyacrylabte monomers
AU562453B2 (en) Ng- acyl derivatives of arginine
AU560450B2 (en) Compositions of arginine and lysine
AU6733381A (en) 3-0-demethyl derivatives of sannamycin c and
AU529650B2 (en) Compositions of l-arginine and alcohols
AU7238581A (en) Tylactone and esters thereof
AU6013780A (en) Compositions of benzothiazolones
AU530249B2 (en) Synergistic compositions of penicillins and cephalosporins
AU544429B2 (en) Compositions of ergots
AU526550B2 (en) Amplifier and symmetrical bridge
AU537113B2 (en) Hydroquinone and mu-amine compositions
AU6286980A (en) Compositions of nylidrin
GB2134525B (en) Preparation of olean-12-ene-3b 30-diol and esters thereof
AU546205B2 (en) Preparation of 3-aryl-3-hydroxyphthalimidines
AU523013B2 (en) Cycloaliphatic acrylate compositions
AU525047B2 (en) Preparation of lactosylurea and n-methylol-lactosylurea
AU526700B2 (en) Preparation of rosin esters